| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential
|
Ceci, Claudia
|
|
|
236 |
C |
p.
|
artikel
|
| 2 |
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response
|
Yu, Jesse
|
|
|
236 |
C |
p.
|
artikel
|
| 3 |
Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
|
de Bartolomeis, Andrea
|
|
|
236 |
C |
p.
|
artikel
|
| 4 |
Early-stage structure-based drug discovery for small GTPases by NMR spectroscopy
|
Yin, Guowei
|
|
|
236 |
C |
p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
236 |
C |
p.
|
artikel
|
| 6 |
Emerging role of an immunomodulatory protein secretoglobin 3A2 in human diseases
|
Kimura, Shioko
|
|
|
236 |
C |
p.
|
artikel
|
| 7 |
Genetic alterations and oxidative stress in T cell lymphomas
|
Kumar, Sushant
|
|
|
236 |
C |
p.
|
artikel
|
| 8 |
MicroRNAs in drug addiction: Current status and future perspectives
|
Zhao, Yue
|
|
|
236 |
C |
p.
|
artikel
|
| 9 |
Myeloperoxidase: Growing importance in cancer pathogenesis and potential drug target
|
Valadez-Cosmes, Paulina
|
|
|
236 |
C |
p.
|
artikel
|
| 10 |
New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis
|
Gautier, Thomas
|
|
|
236 |
C |
p.
|
artikel
|
| 11 |
Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment
|
Feola, S.
|
|
|
236 |
C |
p.
|
artikel
|
| 12 |
Prognostic and predictive molecular biomarkers in advanced colorectal cancer
|
Martelli, Valentino
|
|
|
236 |
C |
p.
|
artikel
|
| 13 |
“RB-reactivator screening” as a novel cell-based assay for discoveries of molecular targeting agents including the first-in-class MEK inhibitor trametinib (trade name: Mekinist)
|
Sakai, Toshiyuki
|
|
|
236 |
C |
p.
|
artikel
|
| 14 |
Recent advances in clinical trials targeting the kynurenine pathway
|
Pires, Ananda Staats
|
|
|
236 |
C |
p.
|
artikel
|
| 15 |
Targeting hedgehog signaling in pancreatic ductal adenocarcinoma
|
Quatannens, Delphine
|
|
|
236 |
C |
p.
|
artikel
|
| 16 |
Targeting RAS in neuroblastoma: Is it possible?
|
Lin, Lei
|
|
|
236 |
C |
p.
|
artikel
|
| 17 |
Targeting the NLRP3 inflammasome in cardiovascular diseases
|
Toldo, Stefano
|
|
|
236 |
C |
p.
|
artikel
|
| 18 |
The immune modifying effects of chemotherapy and advances in chemo-immunotherapy
|
Principe, Daniel R.
|
|
|
236 |
C |
p.
|
artikel
|
Tijdschrift beschrijving